These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 25738669)

  • 1. Valganciclovir for symptomatic congenital cytomegalovirus disease.
    Kimberlin DW; Jester PM; Sánchez PJ; Ahmed A; Arav-Boger R; Michaels MG; Ashouri N; Englund JA; Estrada B; Jacobs RF; Romero JR; Sood SK; Whitworth MS; Abzug MJ; Caserta MT; Fowler S; Lujan-Zilbermann J; Storch GA; DeBiasi RL; Han JY; Palmer A; Weiner LB; Bocchini JA; Dennehy PH; Finn A; Griffiths PD; Luck S; Gutierrez K; Halasa N; Homans J; Shane AL; Sharland M; Simonsen K; Vanchiere JA; Woods CR; Sabo DL; Aban I; Kuo H; James SH; Prichard MN; Griffin J; Giles D; Acosta EP; Whitley RJ;
    N Engl J Med; 2015 Mar; 372(10):933-43. PubMed ID: 25738669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of symptomatic congenital cytomegalovirus infection with intravenous ganciclovir followed by long-term oral valganciclovir.
    Amir J; Wolf DG; Levy I
    Eur J Pediatr; 2010 Sep; 169(9):1061-7. PubMed ID: 20232081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of symptomatic congenital cytomegalovirus infection beyond the neonatal period.
    del Rosal T; Baquero-Artigao F; Blázquez D; Noguera-Julian A; Moreno-Pérez D; Reyes A; Vilas J
    J Clin Virol; 2012 Sep; 55(1):72-4. PubMed ID: 22750017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Valganciclovir Initiated Beyond 1 Month of Age as Treatment of Sensorineural Hearing Loss Caused by Congenital Cytomegalovirus Infection: A Randomized Clinical Trial.
    Kimberlin DW; Aban I; Peri K; Nishikawa JK; Bernatoniene J; Emonts M; Klein N; Bamford A; DeBiasi RL; Faust SN; Jones CE; McMaster P; Caserta M; Ahmed A; Sharland M; Demmler-Harrison G; Hackett S; Sánchez PJ; Shackley F; Kelly D; Dennehy PH; Storch GA; Whitley RJ; Griffiths P;
    J Pediatr; 2024 May; 268():113934. PubMed ID: 38309519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.
    Kimberlin DW; Lin CY; Sánchez PJ; Demmler GJ; Dankner W; Shelton M; Jacobs RF; Vaudry W; Pass RF; Kiell JM; Soong SJ; Whitley RJ;
    J Pediatr; 2003 Jul; 143(1):16-25. PubMed ID: 12915819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of children with congenital cytomegalovirus infection with ganciclovir.
    Michaels MG; Greenberg DP; Sabo DL; Wald ER
    Pediatr Infect Dis J; 2003 Jun; 22(6):504-9. PubMed ID: 12799506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir.
    Meine Jansen CF; Toet MC; Rademaker CM; Ververs TF; Gerards LJ; van Loon AM
    J Perinat Med; 2005; 33(4):364-6. PubMed ID: 16211780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow up.
    Lackner A; Acham A; Alborno T; Moser M; Engele H; Raggam RB; Halwachs-Baumann G; Kapitan M; Walch C
    J Laryngol Otol; 2009 Apr; 123(4):391-6. PubMed ID: 18588736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is lenticulostriated vasculopathy a sign of central nervous system insult in infants with congenital CMV infection?
    Amir J; Schwarz M; Levy I; Haimi-Cohen Y; Pardo J
    Arch Dis Child; 2011 Sep; 96(9):846-50. PubMed ID: 21715394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prolonged treatment with valganciclovir in an infant with congenital cytomegalovirus infection].
    Baquero-Artigao F; Romero Gómez MP
    An Pediatr (Barc); 2009 Jun; 70(6):578-81. PubMed ID: 19423406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies.
    Nassetta L; Kimberlin D; Whitley R
    J Antimicrob Chemother; 2009 May; 63(5):862-7. PubMed ID: 19287011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of congenital cytomegalovirus beyond the neonatal period: an observational study.
    Dorfman L; Amir J; Attias J; Bilavsky E
    Eur J Pediatr; 2020 May; 179(5):807-812. PubMed ID: 31927626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy Options for Infants with Congenital Cytomegalovirus Infection - Implications for Setting Up Neonatal Screening Programs].
    Bührer C; Blankenstein O; Rossi R;
    Z Geburtshilfe Neonatol; 2020 Apr; 224(2):71-78. PubMed ID: 31426118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital cytomegalovirus: what the otolaryngologist should know.
    Duval M; Park AH
    Curr Opin Otolaryngol Head Neck Surg; 2014 Dec; 22(6):495-500. PubMed ID: 25222916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease.
    Kimberlin DW; Acosta EP; Sánchez PJ; Sood S; Agrawal V; Homans J; Jacobs RF; Lang D; Romero JR; Griffin J; Cloud GA; Lakeman FD; Whitley RJ;
    J Infect Dis; 2008 Mar; 197(6):836-45. PubMed ID: 18279073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term hearing outcomes of children with symptomatic congenital CMV treated with valganciclovir.
    McCrary H; Sheng X; Greene T; Park A
    Int J Pediatr Otorhinolaryngol; 2019 Mar; 118():124-127. PubMed ID: 30611098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect on hearing of oral valganciclovir for asymptomatic congenital cytomegalovirus infection.
    Yilmaz Çiftdogan D; Vardar F
    J Trop Pediatr; 2011 Apr; 57(2):132-4. PubMed ID: 20576693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system.
    Oliver SE; Cloud GA; Sánchez PJ; Demmler GJ; Dankner W; Shelton M; Jacobs RF; Vaudry W; Pass RF; Soong SJ; Whitley RJ; Kimberlin DW;
    J Clin Virol; 2009 Dec; 46 Suppl 4(Suppl 4):S22-6. PubMed ID: 19766534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Valganciclovir treatment in a CMV congenital infected infant with sensorineural hearing loss (SNHL) first detected at 4 months of age.
    Hilgendorff A; Daiminger A; Dangel V; Kreuder J; Geidel C; Reiss I; Enders G
    Klin Padiatr; 2009 Dec; 221(7):448-9. PubMed ID: 20013570
    [No Abstract]   [Full Text] [Related]  

  • 20. Viral load in children with congenital cytomegalovirus infection identified on newborn hearing screening.
    Kawada J; Torii Y; Kawano Y; Suzuki M; Kamiya Y; Kotani T; Kikkawa F; Kimura H; Ito Y
    J Clin Virol; 2015 Apr; 65():41-5. PubMed ID: 25766986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.